Brea, CA, United States of America

Sumanta Kumar Pal

This inventor holds 2 USPTO granted patents. Top assignee: Beckman Research Institute, City of Hope. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sumanta Kumar Pal. Retrieved from https://idiyas.com/inventor/sumanta-kumar-pal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2019-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Sumanta Kumar Pal

Introduction

Sumanta Kumar Pal is a notable inventor based in Brea, California. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 2 patents, his work focuses on advancing medical therapies.

Latest Patents

His latest patents include "Compositions and Methods Comprising Clostridium Butyricum for the Treatment of Cancer" and "Androgen Receptor Antagonists." These patents disclose compositions and methods for modulating the androgen receptor, showcasing his commitment to improving cancer therapies.

Career Highlights

Sumanta Kumar Pal is associated with City of Hope, a leading research and treatment center. His work at this institution emphasizes the importance of innovative approaches in the medical field.

Collaborations

He collaborates with esteemed colleagues such as Jeremy Jones and Peter P. Lee, further enhancing the impact of his research.

Conclusion

Sumanta Kumar Pal's contributions to cancer treatment through his patents and collaborations highlight his role as a significant innovator in the medical field. His work continues to inspire advancements in therapeutic methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…